Mati Gill is CEO of AION Labs, a venture studio with a first-of-its-kind company creation model for new start-ups utilizing AI for drug discovery and development. Prior to founding AION Labs, Mati was a senior executive at Teva Pharmaceuticals and served as Chief of Staff for Israel’s Minister of Public Security. He is an IDF veteran (Maj. res.)`and currently serves on the boards of the Israel Advanced Technology Industries Association (IATI) and the Israel America Chamber of Commerce (AmCham).